Ilios Therapeutics
PrivateLast Round
Seed
Sep 5, 2023
Company Overview
Ilios Therapeutics is a biotechnology company that develops multi-functional, brain-penetrant small molecules to treat neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ilios Therapeutics Comparables
Compare Ilios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 79% | |
| Arkuda Therapeutics | 77% | |
| Eikonizo Therapeutics | 77% | |
Ilios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2023 | ||||
| Accelerator | Jul 11, 2022 | ||||
| Pre Seed | Apr 1, 2022 |
Ilios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Launch Lab | Pre Seed |
| Harvard Innovation Labs | Pre Seed |
| Club degli Investitori | Seed |
| Catalisi | Seed |
| MassChallenge Israel | Accelerator, Pre Seed |
| InnoSpark Ventures | Seed |
| Exor Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2023
Seed round raised with participation from Exor Ventures and 3LB Seed Capital.
- Jul 11, 2022
Received funding from MassChallenge Israel.
Ilios Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ilios Therapeutics's valuation, stock price, and market status.